LBO — PELHAM MEDICAL CENTER
IRR: 18.6% | MOIC: 2.35x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.6%
IRR
2.35x
MOIC
$113.1M
Entry EV
$184.1M
Exit EV
$58.2M
Equity Invested
Sources & Uses
S&UTotal · $113.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $43.9M | 38.8% | |
| Sub Debt | $11.0M | 9.7% | |
| Equity | $58.2M | 51.5% | |
| Enterprise Value | $109.8M | 97.1% | |
| Transaction Fees | $3.3M | 2.9% | |
| Total Uses | $113.1M | 100.0% |
Interpretation
INTAt 2.35x MOIC and 18.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $17.5M |
| Exit Ev | $184.1M |
| Net Debt At Exit | $47.5M |
| Equity At Exit | $136.5M |
| Equity Invested | $58.2M |
| Total Value Created | $78.4M |
| Value From Growth | $68.8M |
| Value From Multiple | $5.5M |
| Value From Deleveraging | $7.4M |